Bayer AG - Stockholders' Newsletter Third Quarter 2007

Special Interest

Investor Relations

Press

Jobs and Career

Culture

General Conditions of Use Privacy Statement Imprint Technical Details

Gratifying trend sustained in the third quarter of 2007 – Bayer continues on a successful path

News

Driver for the future of Bayer CropScience is its well-stocked pipeline
Bayer CropScience plan to align its research even more closely with the needs of the new agricultural economy. Limited agricultural land, the steady growth of the world’s population and the impact of climate change are threatening the supply of agricultural products and leading to shortage-driven prices for major commodities. » more

World-scale facility to be built in Antwerp
Bayer MaterialScience is planning to build a world-scale production facility for polymer-filled polyether polyols (polymer polyols, PMPO) at the Antwerp site in Belgium. The plant, involving an investment volume of some €40 million, will have an annual capacity of 60,000 tons and is due on stream in late 2008. » more

A century of culture at Bayer
In the presence of German President Horst Köhler and North Rhine-Westphalia Premier Jürgen Rüttgers, the 100th season of the Bayer Cultural Affairs Department was opened at the beginning of September at the “Erholungshaus” in Leverkusen. » more

News Overview

Key Data
Bayer Group
Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees » more

Bayer Stock Key Data
Investor Information
Bayer’s share price showed mainly lateral movement in the third quarter. » more

Group Management Report
Overview of Sales, Earnings and Financial Position
The Bayer Group continued the positive performance reported for the first half of 2007. » more

Focus
Nexavar® approved in Europe to treat liver cancer
Nexavar®, an oral anti-cancer drug, is the first approved systemic drug therapy for liver cancer » more